SCHEMBL2811299

SCHEMBL2811299

CCCCCCc1ccc2c(c1C(=O)O)Cc1ccccc1O2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 6/20 0.50
MCL1 Q07820 6/20 0.50
BCL2L1 Q07817 5/20 0.50
BAK1 Q16611 5/20 0.50
PPARA Q07869 3/20 0.50
KAT8 Q9H7Z6 3/20 0.50
PPARG P37231 2/20 0.50
SAE1 Q9UBE0 2/20 0.50
EP300 Q09472 2/20 0.50
KAT5 Q92993 2/20 0.50
KAT2A Q92830 1/20 0.50
KAT2B Q92831 1/20 0.50
F7 P08709 3/20 0.44
F3 P13726 3/20 0.44
MMP2 P08253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
ALOX15 P16050 1/20 0.44
ECE1 P42892 1/20 0.44
SGMS1 Q86VZ5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2197127 1.00 BID (0.50) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL2501503 1.00 BID (0.50) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL9055787 1.00 BID (0.50) BIDMCL1BCL2L1BAK1PPARA
Ammonia Solution, Strong SCHEMBL11609491 0.99 BID (0.49) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL135629 0.95 BID (0.43) BIDMCL1BCL2L1BAK1PPARA
P-Xylene SCHEMBL7186308 0.91 BID (0.40) BIDMCL1BCL2L1BAK1PPARA
O-Xylene SCHEMBL6676431 0.91 BID (0.40) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL2804823 0.90 MAOA (0.42) BIDMCL1BCL2L1BAK1PPARA
Potassium Ion SCHEMBL2503961 0.90 CYSLTR2 (0.39) BIDMCL1BCL2L1BAK1PPARA
Zinc Ion SCHEMBL15158157 0.90 CYSLTR2 (0.39) BIDMCL1BCL2L1BAK1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111482278-B Copper oxide ore flotation method 广东省资源综合利用研究所 2022-03-22 CN claimed
CN-111482278-A Copper oxide ore flotation method 广东省资源综合利用研究所 2020-08-04 CN claimed
CN-115386736-A Method for treating laterite-nickel ore by oxygen-enriched side-blown converter 广东邦普循环科技有限公司 2022-11-25 CN disclosed
CN-111482278-A Copper oxide ore flotation method 广东省资源综合利用研究所 2020-08-04 CN disclosed
US-8435966-B2 Associations of xanthogenates and cyclodextrins, and their use BIOSPHINGS AG (DE) 2013-05-07 US disclosed
US-20100240606-A1 ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE BIOSPHINGS AG (DE) 2010-09-23 US disclosed
EP-0825246-B1 Lubricants and functional fluids containing heterocyclic compounds LUBRIZOL CORP (US) 2009-04-01 EP disclosed
US-7051881-B2 Collector for non iron metal sulphide preparation CLARIANT INTERNATIONAL LTD. (CH) 2006-05-30 US disclosed
US-20040099836-A1 Collector for non iron metal sulphide preparation CLARIANT INTERNATIONAL LTD. (CH) 2004-05-27 US disclosed
US-5834407-A ANTIWEAR AND EXTREME PRESSURE OIL ADDITIVE COMPRISING HYDROCARBYL SUBSTITUTED-2-(THIO OR OXO)-1,3-DITHIOLANE, OXATHIOLANE OR THIAZOLIDINES AS SUBSTITUTE FOR ZINC DIALKYL DITHIOPHOSPHATE THE LUBRIZOL CORPORATION (US) 1998-11-10 US disclosed
EP-0825246-A2 Lubricants and functional fluids containing heterocyclic compounds The Lubrizol Corporation (US) 1998-02-25 EP disclosed
EP-0825247-A2 Compositions containing thiocarbonates and acylated-nitrogen containing compounds The Lubrizol Corporation (US) 1998-02-25 EP disclosed
US-4452291-A ADHESION OVERCOATING FOR BRASS OR ZINC COATED STEEL CORDS THE GOODYEAR TIRE & RUBBER COMPANY (US) 1984-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240606-A1 ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE HLA-DRB1, CXCR3, ANTXR2 BID 2856/4885MCL1 2355/4885BCL2L1 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.